These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4644928)

  • 1. Chemotherapy of carcinoma of the breast.
    Huguley CM
    J Med Assoc Ga; 1972 Dec; 61(12):402-3. PubMed ID: 4644928
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of carcinoma of the breast].
    Periti P; Mazzei T
    Minerva Ginecol; 1982 Nov; 34(11):959-62. PubMed ID: 7155423
    [No Abstract]   [Full Text] [Related]  

  • 3. [High-dose chemotherapy of metastatic breast carcinoma].
    Tartarone A; Aieta M; Morritti MG; Palomba G; Romano MP; Lelli G
    Clin Ter; 1998; 149(3):227-30. PubMed ID: 9842107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy induced cytomorphologic changes in breast carcinoma: a potential diagnostic challenge for the histopathologist.
    Gupta R; Arora R; Sharma A; Dinda AK
    Indian J Pathol Microbiol; 2009; 52(4):583-5. PubMed ID: 19805986
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose chemotherapy for primary breast cancer: facts versus anecdotes.
    Hortobagyi GN
    J Clin Oncol; 1999 Nov; 17(11 Suppl):25-9. PubMed ID: 10630258
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved outcome with dose-dense chemotherapy.
    Keith B; Hall R; Scholnik A
    J Clin Oncol; 2004 Feb; 22(4):749; author rpely 751-3. PubMed ID: 14966104
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-dense chemotherapy for breast cancer: the story so far.
    Hudis C
    Br J Cancer; 2000 Jun; 82(12):1897-9. PubMed ID: 10864194
    [No Abstract]   [Full Text] [Related]  

  • 9. Third-line chemotherapy with mitomycin, vinblastine, and carmustine (BCNU) in refractory breast carcinoma: a pilot study.
    Veronesi A; Tirelli U; Galligioni E; Trovò MG; Crivellari D; Donatella Magri M; Roncadin M; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Mar; 66(3):559-61. PubMed ID: 7060044
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania.
    Schwartz GF; Hortobagyi GN
    Cancer; 2004 Jun; 100(12):2512-32. PubMed ID: 15197792
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose density by any other name.
    Hryniuk W; Ragaz J; Peters W
    J Clin Oncol; 2004 Feb; 22(4):750-1; author reply 751-3. PubMed ID: 14966105
    [No Abstract]   [Full Text] [Related]  

  • 12. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.
    Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E
    Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of 2 protocols of polychemotherapy in the treatment of invasive carcinoma of the breast].
    Bianucci P; Pastorino G
    Minerva Med; 1981 Nov; 72(45):3013-7. PubMed ID: 7312202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-intense chemotherapy in cancer management.
    Gonzalez MF; Carr DS
    J S C Med Assoc; 1990 May; 86(5):307-10. PubMed ID: 2342338
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of breast carcinoma].
    Dittrich C
    Wien Med Wochenschr; 2000; 150(4):72-86. PubMed ID: 10829307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-dose chemotherapy for breast cancer: are we at the end or at the end of the beginning?].
    Lopez M
    Clin Ter; 1999; 150(4):259-62. PubMed ID: 10605161
    [No Abstract]   [Full Text] [Related]  

  • 17. Critique of the high-dose chemotherapy studies in breast cancer: a positive look at the data.
    Antman KH
    J Clin Oncol; 1999 Nov; 17(11 Suppl):30-4. PubMed ID: 10630259
    [No Abstract]   [Full Text] [Related]  

  • 18. I.C.I. 46,474 in breast cancer.
    O'Halloran MJ; Maddock PG
    J Ir Med Assoc; 1974 Jan; 67(2):38-9. PubMed ID: 4816312
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of dose-dense chemotherapy in the management of breast cancer.
    Norton L
    Clin Adv Hematol Oncol; 2006 Jan; 4(1):36-7. PubMed ID: 16562368
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer.
    Perkins JB; Effenbein GJ; Fields KK
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):42-6. PubMed ID: 8677448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.